EGFR and colorectal carcinoma: Epidermal growth factor receptor (EGFR) and multiple other RTKs are frequently over-expressed in CRC (García-Aranda and Redondo, 2019), which will usually result in the activation of SHP2 and its downstream signaling (Chen et al., 2016).